Alexandru Nazare, the Minister of Finance of Romania, had a meeting with Kyriakos Pierrakakis, his counterpart from Greece, during the P-TEC forum in Athens, dedicated to economic cooperation between Europe and the USA. The discussions focused on strengthening economic relations, particularly in the fields of energy, infrastructure, and investments. A central topic was the Vertical Natural Gas Transport Corridor, essential for regional energy security. Nazare thanked Greece for its support in Romania's accession to Schengen and the OECD, emphasizing a relationship based on trust and common goals. Initiatives for the development of the Single Capital Market and public-private partnerships for co-financing projects were also discussed. Nazare proposed organizing a similar event in Bucharest to continue the dialogue on these topics.
Sources
Nazare anunță că a convenit cu ministrul grec de Finanțe Kyriakos Pierrakakis consolidarea relațiilor economice între București și Atena, în special în domeniul energiei și infrastructurii
Nazare a convenit la Atena cu omologul său elen consolidarea cooperării economice dintre România și Grecia
Nazare a convenit la Atena cu omologul său elen consolidarea cooperării economice dintre România şi Grecia
FinMin Nazare agrees with Greek counterpart to strengthen economic cooperation between Romania and Greece - AGERPRES
Latest News
08:06
The U.S. Treasury debt has reached $40.047 trillion, exceeding CBO estimates. The rapid increase in the deficit raises concerns in the financial markets.
07:59
The Washington Post: Russians withdraw billions from banks, fearing that Putin will confiscate their deposits to finance his war
07:46
Hungary: The construction of a riverbed threshold on the Danube has raised the water level by 15-20 cm, preventing the shutdown of the turbines at the Paks nuclear power plant.
07:45
Kiev was the target of a new attack with Russian ballistic missiles. At least six people have died and 12 have been injured.
07:37
An experimental cancer vaccine, developed by Moderna and Merck, has shown promising results in patients with melanoma.
See more news